Different medication dosage for morbidly obese patients

PhD research recently completed by pharmacologist Margreke Brill shows that morbidly obese patients should be given a different dosage of the drugs Cefazolin and Midazolam. This could also apply to other drugs such as anti-cancer drugs as well as antibiotics and Margreke Brill is advocating a change in the dosage guidelines. PhD defence 3 December at the Leiden Academic Centre for Drug Research (LACDR).